ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2863

Increased Expression of Extracellular Matrix Proteins in Human Fibroblast Synoviocytes and Lung Epithelial Cells Following Malondialdehyde-Acetaldehyde Adduct (MAA)/Citrullinated Protein Stimulation

Matthew O'Dell1, Logan Duryee 1, Lynell Klassen 1, James O'Dell 2, Bryant England 3, Michael Duryee 1, Geoffrey Thiele 2 and Ted Mikuls 2, 1University of Nebraska Medical Center, Omaha, NE, 2VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha, NE, 3VA Nebraska-Western IA Health Care System & University of Nebraska Medical Center, Omaha

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: extracellular matrix proteins, Fibroblasts, lung and comorbidity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 13, 2019

Title: 6W012: RA – Etiology & Pathogenesis II (2858–2863)

Session Type: ACR Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Recently we have shown that both malondialdehyde-acetaldehyde adducts (MAA) and citrullinated proteins (CIT) are co-localized in joint and lung tissues of patients with rheumatoid arthritis (RA). Therefore, to investigate the possibility that these post-translational modifications pose a synergistic pathogenic role in RA, human synovial fibroblasts and lung epithelial cells were exposed to MAA, CIT or the combination of MAA-CIT and the expression of extracellular matrix proteins (ECMP) were determined. 

Methods: Human fibroblast-like synovial cells (HFLS) and lung epithelial cells (A549) were grown to confluency in 24-well plates.  Following serum starvation, the cells were incubated with 25 µg/ml of human serum albumin (HSA), HSA-MAA, HSA-CIT, or HSA-MAA-CIT for 4 hours (n=5 each group).  RNA was extracted from the cells and subjected to RT-PCR for expression of select ECMPs including fibronectin, collagen, and elastin. 

Results: Stimulation with either HSA-MAA or HSA-MAA-CIT significantly increased fibronectin expression (mRNA) compared to stimulation with HSA or HSA-CIT in both the HFLS (Panel A) and A549 (Panel B) cell lines (Figure 1).  Stimulation with HSA-MAA, HSA-CIT, and HSA-MAA-CIT did not significantly alter collagen expression in either cell line (p >0.05; Panels C and D), although collagen expression was quantitatively increased with HSA-MAA, HSA-CIT, and HSA-MAA-CIT stimulation (vs. HSA alone) in the A549 lung cell line (Panel D). HSA-MAA stimulation significantly (p< 0.001) increased elastin expression in the A549 lung cell line as compared to all other groups (Panel E).  Stimulation with HSA-MAA, HSA-CIT, and HSA-MAA-CIT (vs. HSA) did not significantly alter elastin expression in the HFLS cell line (Panel F).

Conclusion: Proteins that are MAA modified or MAA modified and citrullinated induce fibronectin expression in both lung epithelial cells as well as synovial fibroblasts. This effect appears to be particularly striking in lung epithelial cells where dually modified protein induced a ~15-fold increase in fibronectin exposure. While the impact of these protein modifications on collagen and elastin expression were more variable, these data suggests MAA and/or CIT modifications may expert relevant pathogenic (pro-fibrotic effects) in RA that could be both protein and site-dependent. 

Figure 1. Increase in Extracellular Matrix Proteins in Lung and Synovial Cells. -A-. Increased expression of fibronectin message in A549 cells. Significantly increased in HSA-MAA -p<0.001- and HSA-MAA-CIT -p<0.001- compared to HSA or HSA-CIT antigen stimulation. -B- Increased expression of fibronectin message in HFLS-RA cells. Significantly increased in HSA-MAA -p<0.001- and HSA-MAA-CIT -p<0.001- compared to HSA or HSA-CIT antigen stimulation. -C- No significant differences seen for Collagen expression in either A549 cells or -D- HFLS-RA cells. -E- Elastin expression was significantly increased -p<0.001- in only HSA-MAA stimulated A549 cells compared to all other treatments. -F- No significant increase in elastin was observed in the HFLS-RA cells. -N=6-


Disclosure: M. O'Dell, None; L. Duryee, None; L. Klassen, None; J. O'Dell, None; B. England, None; M. Duryee, None; G. Thiele, None; T. Mikuls, BMS, 2, Horizon, 2.

To cite this abstract in AMA style:

O'Dell M, Duryee L, Klassen L, O'Dell J, England B, Duryee M, Thiele G, Mikuls T. Increased Expression of Extracellular Matrix Proteins in Human Fibroblast Synoviocytes and Lung Epithelial Cells Following Malondialdehyde-Acetaldehyde Adduct (MAA)/Citrullinated Protein Stimulation [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/increased-expression-of-extracellular-matrix-proteins-in-human-fibroblast-synoviocytes-and-lung-epithelial-cells-following-malondialdehyde-acetaldehyde-adduct-maa-citrullinated-protein-stimulation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-expression-of-extracellular-matrix-proteins-in-human-fibroblast-synoviocytes-and-lung-epithelial-cells-following-malondialdehyde-acetaldehyde-adduct-maa-citrullinated-protein-stimulation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology